NUDT1清除氧化DNA前体参与肺动脉高压血管重塑
该研究通过蛋白表达谱分析发现,肺动脉高压(PAH)患者及动物模型的肺动脉平滑肌细胞(PASMCs)中解毒DNA酶NUDT1表达升高;抑制NUDT1可导致氧化核苷酸在DNA中累积、不可修复的DNA损伤、细胞生物能量学紊乱和细胞死亡,并在两种PAH动物模型中用(S)-Crizotinib抑制NUDT1显著减轻肺血管重塑、改善血流动力学和心脏功能。
要点
- PAH-PASMCs中NUDT1表达升高,帮助细胞逃避凋亡并增殖。
- 抑制NUDT1诱导DNA氧化损伤和细胞死亡,减轻血管重塑。
- (S)-Crizotinib在PAH动物模型中改善血流动力学和心脏功能。
核心结论
- PAH-PASMCs通过过表达NUDT1清除氧化核苷酸,逃避凋亡并促进增殖,NUDT1抑制剂可能是PAH的新治疗选择。
研究设计与样本
- 研究采用二维液相色谱-串联质谱对对照和PAH患者的分离PASMCs进行蛋白表达谱分析,并结合多种分子、生化和药理学方法。
主要发现
- PAH患者细胞和组织及动物模型中检测到NUDT1表达增加。
- 体外分子或药理学抑制PAH-PASMCs中NUDT1,诱导氧化核苷酸在DNA中累积、不可修复的DNA损伤(彗星实验)、细胞生物能量学紊乱(Seahorse)和细胞死亡(TUNEL实验)。
- 在两种已建立PAH的动物模型(即单芥子碱和Sugen/缺氧处理大鼠)中,使用(S)-Crizotinib药理学抑制NUDT1显著减少肺血管重塑并改善血流动力学和心脏功能。
临床怎么用
- NUDT1抑制剂(如(S)-Crizotinib)可能为PAH提供新的治疗选项,尤其因其已在癌症临床研究中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Pulmonary arterial hypertension (PAH) is a life-threatening condition characterized by abnormally elevated pulmonary pressures and right ventricular failure. Excessive proliferation and resistance to apoptosis of pulmonary artery smooth muscle cells (PASMCs) is one of the most important drivers of vascular remodeling in PAH, for which available treatments have limited effectiveness.Objectives: To gain insights into the mechanisms leading to the development of the disease and identify new actionable targets.Methods: Protein expression profiling was conducted by two-dimensional liquid chromatography coupled to tandem mass spectrometry in isolated PASMCs from controls and patients with PAH. Multiple molecular, biochemical, and pharmacologic approaches were used to decipher the role of NUDT1 (nudrix hyrolase 1) in PAH.Measurements and Main Results: Increased expression of the detoxifying DNA enzyme NUDT1 was detected in cells and tissues from patients with PAH and animal models. In vitro, molecular or pharmacological inhibition of NUDT1 in PAH-PASMCs induced accumulation of oxidized nucleotides in the DNA, irresolvable DNA damage (comet assay), disruption of cellular bioenergetics (Seahorse), and cell death (terminal deoxynucleotidyl transferase dUTP nick end labeling assay). In two animal models with established PAH (i.e., monocrotaline and Sugen/hypoxia-treated rats), pharmacological inhibition of NUDT1 using (S)-Crizotinib significantly decreased pulmonary vascular remodeling and improved hemodynamics and cardiac function.Conclusions: Our results indicate that, by overexpressing NUDT1, PAH-PASMCs hijack persistent oxidative stress in preventing incorporation of oxidized nucleotides into DNA, thus allowing the cell to escape apoptosis and proliferate. Given that NUDT1 inhibitors are under clinical investigation for cancer, they may represent a new therapeutic option for PAH.
引用
- Vitry G, Paulin R, Grobs Y, et al. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2021. PMID: 33021405. doi:10.1164/rccm.202003-0627OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。